STOCK TITAN

Director at Baird Medical (BDMD) reports 57,180 shares held

(Neutral)
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Baird Medical Investment Holdings Ltd director Ragan Joseph Douglas III filed an initial Form 3 reporting his holdings in the company. The filing shows direct ownership of 57,180 BDMD shares, establishing his starting equity position as a reporting insider, with no specific buy or sell transaction disclosed.

Positive

  • None.

Negative

  • None.
Insider Ragan Joseph Douglas III
Role Director
Type Security Shares Price Value
holding BDMD -- -- --
Holdings After Transaction: BDMD — 57,180 shares (Direct)
Insider holdings 57,180 shares Direct ownership reported on Form 3 by director Ragan Joseph Douglas III
Form 3 regulatory
"Director Ragan Joseph Douglas III filed an initial Form 3 reporting his holdings"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
reporting person regulatory
"The reporting person is identified as director Ragan Joseph Douglas III"
direct ownership financial
"The filing shows direct ownership of 57,180 BDMD shares"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What does the BDMD Form 3 filed by Ragan Joseph Douglas III show?

The Form 3 for Baird Medical (BDMD) shows director Ragan Joseph Douglas III’s initial reported holdings. He reports 57,180 BDMD shares held directly, establishing his starting ownership position as an insider, without detailing any recent purchase or sale activity.

How many Baird Medical (BDMD) shares does Ragan Joseph Douglas III own?

According to the Form 3, director Ragan Joseph Douglas III directly owns 57,180 BDMD shares. This filing records his beneficial ownership as he becomes a reporting insider, rather than documenting a new market transaction in the company’s stock.

Is the BDMD Form 3 a buy or sell transaction?

The BDMD Form 3 is not a buy or sell report. It is an initial ownership statement showing that director Ragan Joseph Douglas III holds 57,180 shares directly, without specifying any associated purchase or sale on the reported date.

What type of ownership is disclosed in the BDMD Form 3?

The BDMD Form 3 discloses direct ownership of the shares. It shows that Ragan Joseph Douglas III holds 57,180 BDMD shares directly in his name, rather than through an intermediary entity or indirect structure such as a trust or partnership.

Why is Ragan Joseph Douglas III’s Form 3 for BDMD important to investors?

The Form 3 is important because it establishes baseline insider ownership. It confirms that director Ragan Joseph Douglas III holds 57,180 BDMD shares, giving investors a clear starting point for tracking any future changes in his stake over time.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Ragan Joseph Douglas III

(Last)(First)(Middle)
304 EAGLE POINT DRIVE

(Street)
WAXHAW NORTH CAROLINA 28173

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026
3. Issuer Name and Ticker or Trading Symbol
Baird Medical Investment Holdings Ltd [ BDMD ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
BDMD57,180D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
/s/ Joseph Douglas Ragan III03/31/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)